hotspot -WSS

hotspot

author：explore 2025-09-30 19:26:19 - browse：774

Ed Silverman on the Breakthrough Summit stage in 2023. — STAT's Ed Silverman on stage at the STAT Breakthrough Summit in 2023. Sarah Gonzalez for STAT

In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. On STAT+ Connect, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss industry events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and exclusive material posted by STAT reporters and editors; and watch events, including live interviews and text-based Ask Me Anything chats.

Last week, Ed Silverman, AKA Pharmalot, hosted an AMA titled “Stump Pharmalot.” During the AMA, Ed discussed gene therapy, his proudest career moments, what he took in high school instead of chemistry, coffee (or, as he calls it, “cups of stimulation”), and more.

Below, you can find a lightly edited transcript of the conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Surgery pushed Ben Carson to fame

explore

WSS

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Brain MRIs reveal impact of 'toxic stress' on Black children

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Why Novartis is going to walk from its acquisition of MorphoSys

Readout LOUD: Venture capital, Gilead, and more M&A

Can gargling with Listerine treat gonorrhea of the mouth?

leisure time

hotspot

focus

Walensky prepares to leave CDC — and Congress — behind

Brain technologies pose threats that are all too real, experts warn

At least 13 dead in Texas as scorching temps continue

The CDC's new social media misinformation war

ChatGPT in medicine: STAT answers readers' burning questions

Cano Health’s bankruptcy is a warning for Medicare Advantage

The cancer drug shortage isn’t new — and neither are the solutions

GSK’s asthma push continues as drug succeeds in Phase 3 trials

23andMe had bad news about my health. I wish a person had delivered it

Welsh Carson private equity firm escapes from FTC antitrust case

explore

Warren pushes Witty on UnitedHealth's control over physicians

Novel spinal cord stimulator treats paralysis without surgery

GSK’s asthma push continues as drug succeeds in Phase 3 trials

The CDC's new social media misinformation war

What’s missing from the debate over nursing home staff minimums

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

explore

focus

explore

Wikipedia